Adipsia after Velagliflozin (Senvelgo) in cats

25 reports to the FDA describe adipsia in cats given Velagliflozin. That is 0.5% of all reports for this medicine, compared with 0.9% across reports for all cat medicines, so it is reported less often than average with this medicine.

25Reports

64%Marked serious

16%Recovered

40%Died or euthanised

3 daysTypical onset

How soon it started

Same day

5 21%

1–2 days

6 25%

3–7 days

3 13%

1–4 weeks

5 21%

Over a month

5 21%

How the animals did

Recovered

4 16%

Still unwell when reported

7 28%

Euthanised

10 40%

Not known

4 16%

Problems reported at the same time

22 88%

13 52%

10 40%

9 36%

8 32%

8 32%

8 32%

8 32%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Velagliflozin cause adipsia in cats?: 25 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 3 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Adipsia with similar medicines

Adipsia after Methimazole 22 reports · 1.2% of its reports

All reported side effects of Velagliflozin in cats · Medicines most reported with adipsia